Compounds > plerixafor
Page last updated: 2024-08-24

plerixafor and alx40 4c

plerixafor has been researched along with alx40 4c in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Broach, JR; Fujii, N; Haribabu, B; Hiramatu, K; Manfredi, JP; Navenot, JM; Omagari, A; Pei, G; Peiper, SC; Tamamura, H; Zhang, WB1
Murakami, T; Yamamoto, N1
Arakaki, R; Fujii, N; Hattori, T; Ibuka, T; Kanbara, K; Nakashima, H; Omagari, A; Otaka, A; Tamamura, H; Xu, Y; Yamamoto, N; Zhang, X1
Fujii, N; Gotoh, K; Kanamoto, T; Kanbara, K; Mochizuki, K; Nakashima, H; Tamamura, H; Yoshimori, M1

Reviews

1 review(s) available for plerixafor and alx40 4c

ArticleYear
[Development of anti-HIV drugs targeted to the coreceptors].
    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1998, Volume: 43, Issue:5

    Topics: Amino Acid Sequence; Animals; Anti-HIV Agents; Antimicrobial Cationic Peptides; Benzylamines; Chemokine CCL5; Cyclams; Heterocyclic Compounds; HIV-1; Humans; Ligands; Molecular Sequence Data; Oligopeptides; Peptides; Receptors, Chemokine

1998

Other Studies

3 other study(ies) available for plerixafor and alx40 4c

ArticleYear
A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists.
    The Journal of biological chemistry, 2002, Jul-05, Volume: 277, Issue:27

    Topics: Amino Acid Substitution; Animals; Anti-HIV Agents; Benzylamines; CHO Cells; Cricetinae; Cyclams; Genes, Reporter; Genetic Variation; GTP-Binding Proteins; Heterocyclic Compounds; Humans; Oligopeptides; Open Reading Frames; Point Mutation; Protein Conformation; Receptors, CXCR4; Recombinant Proteins; Saccharomyces cerevisiae; Signal Transduction; Transfection

2002
A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140.
    Biochemical and biophysical research communications, 1998, Dec-30, Volume: 253, Issue:3

    Topics: Amino Acid Sequence; Anti-HIV Agents; Antimicrobial Cationic Peptides; Benzylamines; Cells, Cultured; Chemokine CXCL12; Chemokines, CXC; Circular Dichroism; Cyclams; DNA-Binding Proteins; Heterocyclic Compounds; HIV-1; Molecular Sequence Data; Oligopeptides; Peptides; Peptides, Cyclic; Receptors, CXCR4; T-Lymphocytes

1998
Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2001, Volume: 7, Issue:1

    Topics: Animals; Anti-HIV Agents; Antibodies, Monoclonal; Benzylamines; CD4 Antigens; CD4-Positive T-Lymphocytes; Chemokine CXCL12; Chemokines; Chemokines, CXC; Chlorocebus aethiops; COS Cells; Cyclams; Drug Synergism; Gene Expression Regulation; Heterocyclic Compounds; HIV Long Terminal Repeat; HIV-1; Humans; Methionine; Oligopeptides; Peptide Fragments; Receptors, CCR5; Receptors, CXCR4; Transfection; Tumor Cells, Cultured; Virus Replication; Zidovudine

2001